Orlistat
Evaluation of Orlistat as Adjuvant Treatment of Obesity in Adults
Empros Pharma AB · Phase 3 · Completed · Enrollment 638
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Orlistat 60 mg | Obesity or overweight | 60 mg | n/r | n/r | n/r |
| Placebo | Obesity or overweight | n/r | n/r | n/r | n/r |